相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Antidepressant-induced internalization of the serotonin transporter in serotonergic neurons
Thorsten Lau et al.
FASEB JOURNAL (2008)
Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B)
Han-Ting Zhang et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Pharmacological properties of the active metabolites of the antidepressants desipramine and citalopram
Jean D. Deupree et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2007)
Blockade of autoreceptor-mediated inhibition of norepinephrine release by atipamezole is maintained after chronic reuptake inhibition
M. Danet Lapiz et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2007)
Appropriate dosing regimens for treating juvenile rats with desipramine for neuropharmacological and behavioral studies
Megan E. Kozisek et al.
JOURNAL OF NEUROSCIENCE METHODS (2007)
Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test
Olivia F. O'Leary et al.
PSYCHOPHARMACOLOGY (2007)
Effect of chronic citalopram on serotonin-related and stress-regulated genes in the dorsal raphe nucleus of the rat
Nashat Abumaria et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2007)
Effect of long-term fluoxetine treatment on the human serotonin transporter in Caco-2 cells
Ruth Iceta et al.
LIFE SCIENCES (2007)
Calcium-dependent interactions of the human norepinephrine transporter with syntaxin 1A
Uhna Sung et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2007)
Neurotransmitter transporters and their impact on the development of psychopharmacology
L Iversen
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Loss of serotonin transporter protein after MDMA and other ring-substituted amphetamines
Tao Xie et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
MJ Millan
PHARMACOLOGY & THERAPEUTICS (2006)
Identification of a novel regulatory mechanism for norepinephrine transporter activity by the IP3 receptor
T Amano et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters
GG Gould et al.
BIOLOGICAL PSYCHIATRY (2006)
Effects of continuous administration of paroxetine on ligand binding site and expression of serotonin transporter protein in mouse brain
K Hirano et al.
BRAIN RESEARCH (2005)
Proteomic analysis of human norepinephrine transporter complexes reveals associations with protein phosphatase 2A anchoring subunit and 14-3-3 proteins
U Sung et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain
DR Thakker et al.
MOLECULAR PSYCHIATRY (2005)
Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors
K Hirano et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Effects of desipramine treatment on tyrosine hydroxylase gene expression in cultured neuroblastoma cells and rat brain tissue
MY Zhu et al.
MOLECULAR BRAIN RESEARCH (2005)
Antidepressant effects assessed using behavior maintained under a differential-reinforcement-of-low-rate (DRL) operant schedule
JM O'Donnell et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2005)
Regulated internalization and phosphorylation of the native norepinephrine transporter in response to phorbol esters - Evidence for localization in lipid rafts and lipid raft-mediated internalization
LD Jayanthi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Onset and early behavioral effects of pharmacologically different antidepressants and placebo in depression
MM Katz et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Immobilization stress elevates tryptophan hydroxylase mRNA and protein in the rat raphe nuclei
FM Chamas et al.
BIOLOGICAL PSYCHIATRY (2004)
Regulation of the norepinephrine transporter by chronic administration, of antidepressants
S Benmansour et al.
BIOLOGICAL PSYCHIATRY (2004)
Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders
DA Morilak et al.
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY (2004)
Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors
JF Cryan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Regarding combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: A double-blind randomized study: Optimizing initial interventions - Reply
JC Nelson et al.
BIOLOGICAL PSYCHIATRY (2004)
The chicken serotonin transporter discriminates between serotonin-selective reuptake inhibitors - A species-scanning mutagenesis study
MB Larsen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Regulatory effects of reboxetine treatment alone, or following paroxetine treatment, on brain noradrenergic and serotonergic systems
GG Gould et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Regional brain metabolic correlates of α-methylparatyrosine-induced depressive symptoms -: Implications for the neural circuitry of depression
JD Bremner et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Regulation of 5-HT1A receptor function in brain following agonist or antidepressant administration
JG Hensler
LIFE SCIENCES (2003)
Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration
A Kugaya et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study
CE Beyer et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2002)
Regulation of norepinephrine transporter abundance by catecholamines and desipramine in vivo
D Weinshenker et al.
BRAIN RESEARCH (2002)
Effects of acute and chronic reboxetine treatment on stress-induced monoamine efflux in the rat frontal cortex
ME Page et al.
NEUROPSYCHOPHARMACOLOGY (2002)
Effects of antidepressants in rats trained to discriminate centrally administered isoproterenol
AM Crissman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Effects of desipramine treatment on norepinephrine transporter gene expression in the cultured SK-N-BE(2)M17 cells and rat brain tissue
MY Zhu et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Assessing antidepressant activity in rodents: recent developments and future needs
JF Cryan et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2002)
Delayed pharmacological effects of antidepressants
A Frazer et al.
MOLECULAR PSYCHIATRY (2002)
Effects of alpha-methyl-para-tyrosine-induced catecholamine depletion in patients with seasonal affective disorder in summer remission
RW Lam et al.
NEUROPSYCHOPHARMACOLOGY (2001)
Down-regulation of the rat serotonin transporter upon exposure to a selective serotonin reuptake inhibitor
S Horschitz et al.
NEUROREPORT (2001)
Effects of short- and long-term exposure to c-AMP and c-GMP on the noradrenaline transporter
LJ Bryan-Lluka et al.
NEUROPHARMACOLOGY (2001)
Reboxetine: A selective norepinephrine reuptake inhibitor for the treatment of depression
AC Scates et al.
ANNALS OF PHARMACOTHERAPY (2000)
How fast are antidepressants?
AJ Gelenberg et al.
JOURNAL OF CLINICAL PSYCHIATRY (2000)
Reboxetine: A pharmacologically potent, selective, and specific norepinephrine reuptake inhibitor
EHF Wong et al.
BIOLOGICAL PSYCHIATRY (2000)
Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha(2)-adrenergic and serotonin(2C) receptors: a comparison with citalopram
MJ Millan et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
分享论文
